|By Marketwired .||
|July 14, 2014 09:23 AM EDT||
TYSONS CORNER, VA -- (Marketwired) -- 07/14/14 -- ScripsAmerica Inc. (OTCBB: SCRC), a leading supplier of prescription, OTC and nutraceutical drugs, today announced that the Company's equity venture, Wholesale Rx "WRx," received and processed $696,808 in orders during the quarter ended June 30, 2014 compared to $26,000 during the same quarter in 2013, prior to ScripsAmerica's involvement with the company.
ScripsAmerica entered into an equity venture with WRx, a Tennessee-based pharmaceutical distributor, during the third quarter of 2013 to provide its independent pharmacy clients with prescription drugs at competitive prices with consistent timely delivery.
ScripsAmerica's CEO, Bob Schneiderman, stated, "The Company is pleased to report significant year over year revenue growth for WRx during the second quarter. In a short time since ScripsAmerica began working with WRx and formed an equity venture with the company, its sales have grown tremendously and are on par with Scrips' overall projected revenue growth in 2014. We expect this level of sales revenue to continue from WRx and further increase in the future as they expand their pharmaceutical distribution capabilities to additional states."
About ScripsAmerica, Inc.
ScripsAmerica, Inc. is a supplier of prescription, OTC and nutraceutical drugs, delivering pharmaceutical products to a wide range of end users across the health care industry. End users include retail pharmacies, hospitals, long-term care facilities and government and home care agencies. For more information, visit www.ScripsAmerica.com.
Safe Harbor Statement
This release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
Seal Point Consulting